Maximum Dose of Augmentin (Amoxicillin/Clavulanate) for Pediatric Patients
The maximum dose of Augmentin (amoxicillin/clavulanate) for pediatric patients is 90 mg/kg/day of the amoxicillin component, with a maximum daily dose of 4000 mg (4 g) per day. 1, 2
Dosing Guidelines by Age and Weight
Children weighing less than 40 kg:
Mild to moderate infections:
Severe infections (including respiratory tract infections in areas with high pneumococcal resistance):
Children weighing 40 kg or more:
- Maximum daily dose: 4000 mg (4 g) of amoxicillin component per day 1
- Typically administered as 875 mg every 12 hours or 500 mg every 8 hours 1
Infants less than 12 weeks (3 months) old:
- Maximum recommended dose: 30 mg/kg/day divided every 12 hours 1
- This lower dosage is due to incompletely developed renal function affecting amoxicillin elimination 1
Formulation Considerations
Different formulations of Augmentin provide different ratios of amoxicillin to clavulanate:
- Standard formulation: 4:1 ratio 3
- High-dose formulation (Augmentin ES-600): 14:1 ratio, providing 90 mg/kg/day of amoxicillin component while maintaining the same daily dose of clavulanate as regular strength formulation 3, 4
Dosing for Specific Conditions
For Respiratory Tract Infections:
- Community-acquired pneumonia: 90 mg/kg/day of amoxicillin component in 2 doses 2
- For β-lactamase producing H. influenzae: Amoxicillin/clavulanate with amoxicillin component at 45 mg/kg/day in 3 doses or 90 mg/kg/day in 2 doses 2
For Otitis Media:
- Recurrent or persistent cases: High-dose amoxicillin/clavulanate (90/6.4 mg/kg/day) in two divided doses 4, 3
Administration Recommendations
- Administer at the start of a meal to minimize gastrointestinal intolerance 1
- Treatment should continue for a minimum of 48-72 hours beyond symptom resolution 1
- For Streptococcus pyogenes infections, treatment should continue for at least 10 days to prevent acute rheumatic fever 1
Safety Considerations and Adverse Effects
- Most common adverse effects are mild gastrointestinal disturbances, particularly diarrhea 5, 6
- Twice-daily dosing may result in fewer gastrointestinal side effects than three-times-daily dosing 6
- Patients with severe renal impairment (GFR <30 mL/min) should NOT receive the 875 mg dose 1
Clinical Pearls
- The high-dose formulation was developed specifically to address drug-resistant Streptococcus pneumoniae while maintaining a favorable safety profile 4, 3
- Compliance is generally better with twice-daily dosing compared to three-times-daily dosing (82.8% vs. 73.3%) 6
- After reconstitution, oral suspension must be discarded after 14 days 1
Remember that dosing should be adjusted based on the severity of infection and local patterns of antimicrobial resistance, particularly for pneumococcal resistance 2, 7.